top of page
.png)
Onco-Summaries: Daily Oncology Updates at a Glance
12/08/2025 Perioperative pembrolizumab + enfortumab vedotin significantly improved EFS, OS and pCR in cisplatin-ineligible MIBC ( Ref )...
Oncofocus Team
Aug 13, 20251 min read
Onco-Summaries: Daily Oncology Updates at a Glance
31/07/2025 MaxCyte and Anocca AB signed a Strategic Platform Licensing Agreement to advance TCR-T cell therapies ( Ref ) MaxCyte signed a...
Oncofocus Team
Aug 4, 20251 min read
bottom of page